Education
About Us
Working with TipRanks
Follow Us
Althea Group Holdings Ltd. (AU:PKP)
ASX:PKP
PKP Stock Chart & Stats
AU$0.02
AU$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.04
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.24M
Market Cap
AU$20.86M
Enterprise ValueAU$19.95M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.47
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,158,891,500
10 Day Avg. Volume1,829,506
30 Day Avg. Volume1,236,918
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Free Cash Flow GrowthA 28.49% free cash flow growth rate indicates an improving cash-generation trajectory despite current negatives. If sustained, growing FCF can reduce external financing needs, support working capital and targeted investments, and provide runway for restructuring or product commercialization over the next several quarters.
Cash Conversion EfficiencyA FCF-to-net-income ratio above 1.0 (1.13) shows the company is converting reported earnings into cash efficiently, signaling improving cash quality. Over a multi‑quarter horizon, reliable conversion helps liquidity management, reduces dependence on debt or equity raises, and supports operational continuity if maintained.
Industry ExposureOperating in the specialty and generic drug sector provides structural demand and prescription-driven revenue potential. This industry alignment tends to offer recurring sales and product longevity, which can stabilize revenue baselines and support recovery strategies if the company can execute product and commercial plans consistently.
Bears Say
Revenue DeclineA severe revenue contraction (−37.84% in the latest year) signals materially shrinking scale and likely loss of product demand or market share. Persistent top-line decline undermines economies of scale, reduces cover for fixed costs, and limits the firm's ability to invest in R&D, commercialization, or recovery initiatives over the medium term.
Structural UnprofitabilityDeep negative margins (net margin −53.87%, EBIT −26.57%) indicate operations do not cover costs at current scale. Such structural unprofitability consumes cash and necessitates ongoing external funding or cost restructuring, impeding the company's ability to sustainably reinvest in product development or sales capacity absent a clear margin recovery plan.
Balance Sheet StressNegative shareholders' equity and an extreme debt-to-equity ratio (−9.05) point to solvency pressure and limited financial flexibility. Over months this elevates risks of covenant breaches, creditor action, dilution, or restructuring, constraining the firm's ability to fund operations, pursue strategic investments, or withstand further revenue shocks.
Althea Group Holdings Ltd. News
PKP FAQ
What was Althea Group Holdings Ltd.’s price range in the past 12 months?
Althea Group Holdings Ltd. lowest share price was AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is Althea Group Holdings Ltd.’s market cap?
Althea Group Holdings Ltd.’s market cap is AU$20.86M.
When is Althea Group Holdings Ltd.’s upcoming earnings report date?
Althea Group Holdings Ltd.’s upcoming earnings report date is Aug 27, 2026 which is in 167 days.
How were Althea Group Holdings Ltd.’s earnings last quarter?
Althea Group Holdings Ltd. released its earnings results on Feb 27, 2026. The company reported -AU$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.006.
Is Althea Group Holdings Ltd. overvalued?
According to Wall Street analysts Althea Group Holdings Ltd.’s price is currently Undervalued.
Does Althea Group Holdings Ltd. pay dividends?
Althea Group Holdings Ltd. does not currently pay dividends.
What is Althea Group Holdings Ltd.’s EPS estimate?
Althea Group Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Althea Group Holdings Ltd. have?
Althea Group Holdings Ltd. has 1,158,891,500 shares outstanding.
What happened to Althea Group Holdings Ltd.’s price movement after its last earnings report?
Althea Group Holdings Ltd. reported an EPS of -AU$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.882%.
Which hedge fund is a major shareholder of Althea Group Holdings Ltd.?
Currently, no hedge funds are holding shares in AU:PKP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Althea Group Holdings Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-38.23%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-13.37%
Trailing 12-Months
Company Description
Althea Group Holdings Ltd.
Peak Processing Limited, together with its subsidiaries, manufactures, distributes, and sells recreational cannabis products in Canada and the United States. The company offers cannabis products, including beverages, hydrocarbon extracts, oils, vapes, oils, topicals, powders, infused flowers, and edibles. It also provides market insights and analysis, product development, manufacturing, commercialization, distribution, and product rework services. The company sells its products through retail stores. The company was formerly known as Althea Group Holdings Limited and change its name to Peak Processing Limited in November 2025. Peak Processing Limited was founded in 2016 and is based in Melbourne, Australia.